How BSV is bridging the gap between big pharma and its consumers

Phillip Runyan says Bitcoin-powered Veridat allows auditors to access information on clinical trials, on a transaction to transaction basis.

Click here to read the full article.

Recommended for you

This Week in AI: US, China clash; Amazon eyes in-house chips

China and the U.S. are butting heads anew over trade, while Amazon eyes to become a major player in the...

By Patrick Thompson

November 15, 2024

CREATE MORE Act and its impact on emerging tech

Philippine President Ferdinand Marcos Jr. signed the CREATE MORE Act into law, focusing on lowering corporate taxes, simplifying business processes,...

By Claire Celdran

November 15, 2024